REPORT ID 4760

United States Subunit Vaccine Market Report 2017

Publish Date
19-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the United States Subunit Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Subunit Vaccine in these regions, from 2012 to 2022 (forecast).

United States Subunit Vaccine market competition by top manufacturers/players, with Subunit Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GE Healthcare Life Sciences
    GSK
    Reber Genetics
    Merck
    Sanofi
    Virbac
    Shenzhen Kangtai Biological Products
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Live Attenuated Vaccine
    Inactivated Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinics
    Public Services
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Subunit Vaccine Market Report 2017
1 Subunit Vaccine Overview
    1.1 Product Overview and Scope of Subunit Vaccine
    1.2 Classification of Subunit Vaccine by Product Category
        1.2.1 United States Subunit Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Subunit Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Live Attenuated Vaccine
        1.2.4 Inactivated Vaccine
    1.3 United States Subunit Vaccine Market by Application/End Users
        1.3.1 United States Subunit Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Public Services
        1.3.5 Others
    1.4 United States Subunit Vaccine Market by Region
        1.4.1 United States Subunit Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Subunit Vaccine Status and Prospect (2012-2022)
        1.4.3 Southwest Subunit Vaccine Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Subunit Vaccine Status and Prospect (2012-2022)
        1.4.5 New England Subunit Vaccine Status and Prospect (2012-2022)
        1.4.6 The South Subunit Vaccine Status and Prospect (2012-2022)
        1.4.7 The Midwest Subunit Vaccine Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Subunit Vaccine (2012-2022)
        1.5.1 United States Subunit Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 United States Subunit Vaccine Revenue and Growth Rate (2012-2022)

2 United States Subunit Vaccine Market Competition by Players/Suppliers
    2.1 United States Subunit Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Subunit Vaccine Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Subunit Vaccine Average Price by Players/Suppliers (2012-2017)
    2.4 United States Subunit Vaccine Market Competitive Situation and Trends
        2.4.1 United States Subunit Vaccine Market Concentration Rate
        2.4.2 United States Subunit Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Subunit Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Subunit Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Subunit Vaccine Sales and Market Share by Region (2012-2017)
    3.2 United States Subunit Vaccine Revenue and Market Share by Region (2012-2017)
    3.3 United States Subunit Vaccine Price by Region (2012-2017)

4 United States Subunit Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Subunit Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Subunit Vaccine Revenue and Market Share by Type (2012-2017)
    4.3 United States Subunit Vaccine Price by Type (2012-2017)
    4.4 United States Subunit Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Subunit Vaccine Sales (Volume) by Application (2012-2017)
    5.1 United States Subunit Vaccine Sales and Market Share by Application (2012-2017)
    5.2 United States Subunit Vaccine Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Subunit Vaccine Players/Suppliers Profiles and Sales Data
    6.1 GE Healthcare Life Sciences
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Subunit Vaccine Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GE Healthcare Life Sciences Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 GSK
        6.2.2 Subunit Vaccine Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 GSK Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Reber Genetics
        6.3.2 Subunit Vaccine Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Reber Genetics Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Merck
        6.4.2 Subunit Vaccine Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Merck Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Sanofi
        6.5.2 Subunit Vaccine Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Sanofi Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Virbac
        6.6.2 Subunit Vaccine Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Virbac Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Shenzhen Kangtai Biological Products
        6.7.2 Subunit Vaccine Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Shenzhen Kangtai Biological Products Subunit Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Subunit Vaccine Manufacturing Cost Analysis
    7.1 Subunit Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Subunit Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Subunit Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Subunit Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Subunit Vaccine Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Subunit Vaccine Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Subunit Vaccine Sales Volume Forecast by Type (2017-2022)
    11.3 United States Subunit Vaccine Sales Volume Forecast by Application (2017-2022)
    11.4 United States Subunit Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer